IRCT138808271141N7CompletedPhase 3
The efficacy of Cabergoline in preventing ovarian hyper stimulation in ART program
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Royan Institute
- Enrollment
- 130
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15 years to 37 years (—)
- Sex
- Female
Inclusion Criteria
- •Inclusion Criteria: risk of developing OHSS, defined by the development of 20–30 follicles larger than 12 mm in diameter and retrieval of more than 20 oocytes, ovarian stimulation with long protocol
Exclusion Criteria
- •Coasting cases, age more than 37 years, previous pelvic surgery, Intramural or submucosal myoma sizes > 5 CM, uterine polyps, Smoking, or alcohol addiction
Investigators
Similar Trials
Not yet recruiting
Phase 4
Cabergoline as an Adjunct to Ovulation Induction in Infertile Women with EndometriosisCTRI/2024/03/063714il
Recruiting
Phase 3
Diosmin plus cabergoline for prevention of Ovarian Hyperstimulation Syndrome in high-risk women undergoing intracytoplasmic sperm injection (ICSI)infertile womenOvarian Hyperstimulation SyndromePCO (polycystic ovarian syndrome)Reproductive Health and Childbirth - Fertility including in vitro fertilisationACTRN12614000535673khalid abd aziz mohamed250
Active, not recruiting
Phase 1
The effect of cabergoline in infertile women on peritoneal endometriosis related dysmenorrhea, chronic pelvic pain and fertilityCTIS2022-500792-31-00Turku University Central Hospital80
Active, not recruiting
Phase 1
Cabergoline as a Preventive Treatment for Chronic MigraineMedDRA version: 20.0Level: LLTClassification code 10020739Term: HyperprolactinemiaSystem Organ Class: 100000004860MigraineEUCTR2021-005579-38-DKAarhus University Hospital, Department of Endocrinology32
Completed
Not Applicable
Ovarian Hyperstimulation Syndrome and CabergolinePolycystic Ovarian SyndromeOvarian Hyperstimulation SyndromeNCT01569256Etlik Zubeyde Hanim Womens' Health and Teaching Hospital40